Scholars Central

Conference abstract

Why whooping cough is back and what vaccines need to be developed to counter it: Next generation pertussis vaccines and relevance of adenylate cyclase toxin-hemolysin

Authors: Peter Sebo

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The adenylate cyclase toxin-hemolysin (ACT, AC-Hly or CyaA) is a key virulence factor of Bordetella pertussis. It targets bactericidal activities of phagocytes such as oxidative burst and complement or antibody-mediated opsonophagocytic killing of bacteria. Through cAMP signaling, CyaA skews also TLR-triggered maturation of dendritic cells inhibiting proinflammatory IL-12 and TNF-α secretion and enhancing IL-10 production and Treg expansion likely hampering also induction of adaptive immune responses to Bordetella infections. Non-enzymatic CyaA toxoid is a potent protective antigen and adjuvant that boosts immunogenicity of co-administered B. pertussis antigens and improves potency of acellular pertussis (aP) vaccines in mice. This makes CyaA to a prime antigen candidate for inclusion into a next generation of aP vaccines. Moreover, recombinant CyaA toxoids were recently shown to be safe in humans in frame of phase-I clinical evaluation of a CyaA-based immunotherapeutic vaccine that induces Th1-polarized CD8+ cytotoxic T-lymphocyte response targeting cervical tumors. In the last part of the lecture, the need for and ways of making a safer next generation whole cell pertussis vaccine (wP) for most developed countries will be outlined.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Peter Sebo”